UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
- --------------------------------------------------------------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
COCENSYS, INC.
(Name of Issuer)
Common Stock, $0.001 Par Value
(Title of Class of Securities)
0001912631
(CUSIP Number)
Wayne P. Merkelson, Esq.
Novartis Corporation
556 Morris Avenue
Summit, NJ 07901-1398
Telephone: (908) 522-6777
(Name, Address and Telephone Number of
Person Authorized to Receive Notices and
Communications)
Copy to:
Spencer D. Klein, Esq.
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Telephone: (212) 848-4000
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 0001912631
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Novartis AG
-----------
(2) Check the Appropriate Box if a Member of Group (See Instructions)
|_| (a)
|_| (b)
(3) SEC Use Only
(4) Citizenship or Place of Organization Switzerland
Number of (5) Sole Voting Power 0
Shares ---
Beneficially (6) Shared Voting Power 2,378,192
Owned by -----------
Each (7) Sole Dispositive Power 0
Reporting ---
Person (8) Shared Dispositive Power 2,378,192
With -----------
- ----
(9) Aggregate Amount Beneficially Owned by Each Reporting Person 2,378,192
----------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
(11) Percent of Class Represented by Amount in Row (9)
10.43%
-------
(12) Type of Reporting Person (See Instructions) CO
----
<PAGE>
CUSIP No. 0001912631
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Novartis Produkte AG
--------------------
(2) Check the Appropriate Box if a Member of Group (See Instructions)
|_| (a)
|_| (b)
(3) SEC Use Only
(4) Citizenship or Place of Organization Switzerland
Number of (5) Sole Voting Power 0
Shares ---
Beneficially (6) Shared Voting Power 2,378,192
Owned by -----------
Each (7) Sole Dispositive Power 0
Reporting ---
Person (8) Shared Dispositive Power 2,378,192
With -----------
- ----
(9) Aggregate Amount Beneficially Owned by Each Reporting Person 2,378,192
----------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
(11) Percent of Class Represented by Amount in Row (9)
10.43%
--------
(12) Type of Reporting Person (See Instructions) CO
----
<PAGE>
Item 1. Issuer
(a) CoCensys, Inc.
(b) 201 Technology Drive
Irvine, California 92618
Item 2. Person Filing
(a) Name of Person Filing: Novartis AG ("Novartis") and Novartis
Produkte AG.
(b) Address of Principal Office: The principal offices of
Novartis and Novartis Produkte AG are located at
Schwarzwaldallee 215, CH-4002, Basel, Switzerland.
(c) Citizenship: Novartis and Novartis Produkte AG are Swiss
corporations.
(d) Title of Class of Securities: Common Stock, $0.001 par value.
(e) CUSIP Number: 0001912631
Item 3. Not applicable.
Item 4. Ownership
(a) Amount Beneficially Owned: 2,378,192
(b) Percent of Class: 10.43%
(c) Number of shares as to which each person has:
(i) Sole Voting Power: 0
(ii) Shared Voting Power: 2,378,192
(iii) Sole Dispositive Power: 0
(iv) Shared Dispositive Power: 2,378,192
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not Applicable.
Item 9. Notice of Dissolution of Group
Not Applicable.
<PAGE>
Item 10. Certification if Statement Filed Pursuant to Rule 13d-1(b)
Not Applicable.
<PAGE>
SIGNATURE
After reasonable inquiry to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 13, 1998
NOVARTIS AG
By: /s/ Dr. Urs Barlocher
-----------------------------
General Counsel
By: /s/ Christoph Mader
-----------------------------
Senior Corporate Counsel
<PAGE>
SIGNATURE
After reasonable inquiry to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 13, 1998
NOVARTIS PRODUKTE AG
By: /s/ Dr. Urs Barlocher
-----------------------------
Authorized Signatory
By: /s/ Anita Buchli
-----------------------------
Authorized Signatory
